Combination Therapy With Dalfampridine and Locomotor Training for Chronic, Motor Incomplete Spinal Cord Injury
Status:
Completed
Trial end date:
2017-10-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy, safety, and tolerability of treatment
with dalfampridine in combination with locomotor training in persons with chronic, motor
incomplete SCI.
Phase:
Phase 2
Details
Lead Sponsor:
Kessler Foundation
Collaborators:
Acorda Therapeutics National Institute on Disability, Independent Living, and Rehabilitation Research U.S. Department of Education